Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
INFINITY PHARMACEUTICALS, INC. has filed 1,187 SEC EDGAR filings since 09 May 2000

SEC filing history

Showing 376-400 of 745 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
03 Sep 2015
Reporting date
01 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Sep 2015
Reporting date
01 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-134438

CT ORDER filing

Filing date
27 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

8-K

Filing date
06 Aug 2015
Reporting date
06 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60943

SC 13G/A filing

Filing date
10 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60943

SC 13G/A filing

Filing date
10 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-205585

S-8

Filing date
09 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jun 2015
Reporting date
25 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

FORM 8-K

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 May 2015
Reporting date
27 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60943

SC 13G/A filing

Filing date
07 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

FORM 8-K

Filing date
07 May 2015
Reporting date
07 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

FORM 8-K

Filing date
06 May 2015
Reporting date
06 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-203890

FORM S-3ASR

Filing date
06 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .